SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Phage Therapeutics International Inc – ‘10SB12G/A’ on 12/5/01 – EX-10.30

On:  Wednesday, 12/5/01   ·   Accession #:  912057-1-542027   ·   File #:  0-31961

Previous ‘10SB12G’:  ‘10SB12G/A’ on 6/6/01   ·   Latest ‘10SB12G’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/05/01  Phage Therapeutics Int’l Inc      10SB12G/A             24:1.4M                                   Merrill Corp/FA

Amendment to Registration of Securities of a Small-Business Issuer   —   Form 10-SB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10SB12G/A   Amendment to Registration of Securities of a        HTML    725K 
                          Small-Business Issuer                                  
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     19K 
 3: EX-10.1     Material Contract                                   HTML     34K 
11: EX-10.10    Material Contract                                   HTML     79K 
12: EX-10.11    Material Contract                                   HTML     78K 
13: EX-10.12    Material Contract                                   HTML     53K 
14: EX-10.13    Material Contract                                   HTML     79K 
15: EX-10.14    Material Contract                                   HTML     22K 
16: EX-10.15    Material Contract                                   HTML     25K 
 4: EX-10.2     Material Contract                                   HTML     30K 
17: EX-10.22    Material Contract                                   HTML     38K 
18: EX-10.23    Material Contract                                   HTML     43K 
19: EX-10.24    Material Contract                                   HTML     43K 
20: EX-10.28    Material Contract                                   HTML     44K 
21: EX-10.29    Material Contract                                   HTML     64K 
 5: EX-10.3     Material Contract                                   HTML     42K 
22: EX-10.30    Material Contract                                   HTML     18K 
23: EX-10.33    Material Contract                                   HTML     46K 
 6: EX-10.4     Material Contract                                   HTML     80K 
 7: EX-10.5     Material Contract                                   HTML     22K 
 8: EX-10.6     Material Contract                                   HTML     18K 
 9: EX-10.8     Material Contract                                   HTML     19K 
10: EX-10.9     Material Contract                                   HTML     23K 
24: EX-21       Subsidiaries of the Registrant                      HTML      9K 


EX-10.30   —   Material Contract
Exhibit Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Management Agreement
"QuickLinks

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Prepared by MERRILL CORPORATION  

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 10.30


MANAGEMENT AGREEMENT

THIS AGREEMENT made effective September 1, 1998.

BETWEEN:

OF THE FIRST PART

AND:

OF THE SECOND PART

WHEREAS:

1.
The Corporation is engaged in the Bio-Technology industry and requires the services of a manager to fulfill the day-to-day responsibilities imposed on the Corporation; and

2.
The Manager has agreed to act as Manager of the Corporation;

NOW THEREFORE THIS AGREEMENT WITNESSETH that for and in consideration of the premises, the mutual covenants and agreements herein contained the parties hereto hereby agree as follows:

1.
The Corporation hereby agree to retain the services of the Manager.

2.
The retention of the Manager shall be for a month to month period commencing September 1, 1998, and continuing thereafter from year to year unless and until terminated as hereinafter provided.

3.
The Manager shall serve the Corporation and any subsidiaries from time to time owned by the Corporation in such capacity or capacities and shall perform such duties and exercise such powers as may from time to time be determined by Resolution of the Board of Directors of Corporation.

4.
Subject to the control vested in the Board of Directors with respect to the activities of the Manager, the Manager shall have from the date of commencement of this Agreement, the authority and responsibility to deal with the following subject matters:

a.
maintaining the services of accounting and legal professionals for the purposes of reviewing all prospects introduced to the Corporation for investment or participation;

b.
arranging for and securing financing for the Corporation as may be permitted by regulatory bodies;

c.
arranging for timely disclosure of all material facts in the affairs of the Corporation, such as regulatory filings, timely financial disclosures and issuance of News Releases;

d.
establishing and maintaining suitable banking relations;


5.
The remuneration of the Manager for his services hereunder shall be at the rate of $10,000 US per month for a term of one year (together with any such increments thereto as the Board of Directors of the Corporation may from time to time a lot) payable in equal monthly installments in advance of the first business day of each calendar month, the first such installment to be payable on the first day of March, 1999.

6.
The Manager shall be reimbursed for all traveling and out-of-pocket expenses actually and properly incurred by it in connection with its duties hereunder. In respect of expenses, the Manager shall provide statements and vouchers to the Corporation as and when required by it.

7.
The terms "subsidiary" and "subsidiaries" as used herein mean any corporation or Corporation of which more than 50% of the outstanding shares carrying voting rights at all times are for the time being owned by or held for the benefit of the Corporation and include any corporation or company in like relation to a subsidiary.

8.
Any notice required or permitted to be given hereunder to the Manager or to the Corporation shall be given by registered mail, postage prepaid, addressed to the Manager or the Corporation at their respective registered offices from time to time in existence. Any notice mailed as aforesaid shall be deemed to have been received y the Addressee on the second business day following the date of mailing.

9.
This Agreement may be terminated:

a.
by the Manager or sixty (60) days written notice to the Corporation; or

b.
by the Corporation on sixty (60) days written notice to the Manager.

10.
The provisions of the Agreement shall be governed by and interpreted in accordance with the laws of the State of Washington.

11.
This Agreement may be executed by facsimile and in any number of counterparts with the same effect as if all parties to this Agreement had signed the same document and all counterparts will be construed together and will constitute one and the same instrument, and any facsimile signature shall be taken as an original.

IN WITNESS WHEREOF, the parties hereto have hereunto caused these presents to be executed, as of the day and year first above written.

PHAGE THERAPEUTICS INTERNATIONAL, INC.   STEALTH INVESTMENTS CORP.

/s/ Richard C. Honour

Per: Authorized Signatory

 

/s/ Darren Pylot

Per: Authorized Signatory



QuickLinks

MANAGEMENT AGREEMENT

Dates Referenced Herein

This ‘10SB12G/A’ Filing    Date    Other Filings
Filed on:12/5/01None on these Dates
9/1/98
 List all Filings 
Top
Filing Submission 0000912057-01-542027   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 10:22:58.1am ET